AU598602B2 - Ifosphamide lyophilisate and process for its preparation - Google Patents
Ifosphamide lyophilisate and process for its preparation Download PDFInfo
- Publication number
- AU598602B2 AU598602B2 AU80529/87A AU8052987A AU598602B2 AU 598602 B2 AU598602 B2 AU 598602B2 AU 80529/87 A AU80529/87 A AU 80529/87A AU 8052987 A AU8052987 A AU 8052987A AU 598602 B2 AU598602 B2 AU 598602B2
- Authority
- AU
- Australia
- Prior art keywords
- ifosfamide
- weight
- lyophilisate
- hexitol
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased, expires
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cephalosporin Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Control Of El Displays (AREA)
- Amplifiers (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3637089 | 1986-10-31 | ||
| DE3637089 | 1986-10-31 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU8052987A AU8052987A (en) | 1988-05-05 |
| AU598602B2 true AU598602B2 (en) | 1990-06-28 |
Family
ID=6312873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU80529/87A Ceased AU598602B2 (en) | 1986-10-31 | 1987-10-30 | Ifosphamide lyophilisate and process for its preparation |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0265812B1 (enExample) |
| JP (1) | JPS63159319A (enExample) |
| KR (1) | KR900003491B1 (enExample) |
| AT (1) | ATE55250T1 (enExample) |
| AU (1) | AU598602B2 (enExample) |
| CA (1) | CA1314231C (enExample) |
| DD (1) | DD262582A5 (enExample) |
| DE (1) | DE3764235D1 (enExample) |
| DK (1) | DK169308B1 (enExample) |
| EG (1) | EG18333A (enExample) |
| ES (1) | ES2017982B3 (enExample) |
| FI (1) | FI87140C (enExample) |
| GE (1) | GEP19971025B (enExample) |
| GR (1) | GR3000708T3 (enExample) |
| HU (1) | HU197987B (enExample) |
| IL (1) | IL84312A (enExample) |
| IN (1) | IN168119B (enExample) |
| LV (1) | LV10051B (enExample) |
| MX (1) | MX8958A (enExample) |
| NO (1) | NO873860L (enExample) |
| PT (1) | PT86032B (enExample) |
| RU (1) | RU1836079C (enExample) |
| UA (1) | UA11075A (enExample) |
| YU (1) | YU197387A (enExample) |
| ZA (1) | ZA878183B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE58900183D1 (de) * | 1988-03-19 | 1991-08-29 | Asta Pharma Ag | Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung. |
| US5227373A (en) * | 1991-10-23 | 1993-07-13 | Bristol-Myers Squibb Co. | Lyophilized ifosfamide compositions |
| WO1995007083A1 (en) * | 1993-09-10 | 1995-03-16 | F.H. Faulding & Co. Limited | Ifosfamide lyophilisate composition |
| DE19529057B4 (de) * | 1995-08-08 | 2007-12-13 | Baxter Healthcare S.A. | Ifosfamid-Lyophilisat-Zubereitungen |
| JP2002505282A (ja) * | 1998-03-03 | 2002-02-19 | 塩野義製薬株式会社 | ホスホリパーゼ阻害剤の［［３−（２−アミノ−１，２−ジオキソエチル）−２−エチル−１−フェニルメチル）−１ｈ−インドール−４−イル］オキシ］酢酸ナトリウムを含む薬学的組成物 |
| MXPA05002453A (es) * | 2002-09-05 | 2005-05-27 | Bharat Serums & Vaccines Ltd | Composicion estable liquida de oxazafosforina con el 2-mercaptoetansulfonato de sodio. |
| NZ540484A (en) * | 2002-12-02 | 2008-03-28 | Bharat Serums & Vaccines Ltd | Stable, clear, aqueous ifosfamide compositions for parenteral administration and a process for their preparation |
| US8436190B2 (en) * | 2005-01-14 | 2013-05-07 | Cephalon, Inc. | Bendamustine pharmaceutical compositions |
| SI2071917T1 (sl) * | 2006-09-29 | 2013-03-29 | Infa S.A. | Pakirni sistem za farmacevtske sestavke in komplet za intravensko aplikacijo |
| WO2016087001A1 (en) * | 2014-12-04 | 2016-06-09 | Huawei Technologies Co., Ltd. | Load allocation in a data communication network |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3732340A (en) * | 1966-07-11 | 1973-05-08 | Asta Werke Ag Chem Fab | N',o-propylene phosphoric acid ester diamides |
| US4537883A (en) * | 1982-11-12 | 1985-08-27 | Mead Johnson & Company | Lyophilized cyclophosphamide |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2750207A1 (de) * | 1977-05-09 | 1978-11-16 | Walton J Smith | Gefriergetrocknete zusammensetzungen, insbesondere gefriergetrocknete pharmazeutische praeparate und verfahren zu deren herstellung |
| EP0083439B1 (de) * | 1981-12-31 | 1989-07-26 | ASTA Pharma AG | 4-Sulfido-oxazaphosphorine und deren Verwendung bei der Krebsbekämpfung und zur Immunsuppression |
-
1987
- 1987-09-15 NO NO873860A patent/NO873860L/no unknown
- 1987-10-20 DE DE8787115322T patent/DE3764235D1/de not_active Expired - Lifetime
- 1987-10-20 AT AT87115322T patent/ATE55250T1/de not_active IP Right Cessation
- 1987-10-20 ES ES87115322T patent/ES2017982B3/es not_active Expired - Lifetime
- 1987-10-20 EP EP87115322A patent/EP0265812B1/de not_active Expired - Lifetime
- 1987-10-23 MX MX895887A patent/MX8958A/es unknown
- 1987-10-26 IN IN837/CAL/87A patent/IN168119B/en unknown
- 1987-10-27 FI FI874727A patent/FI87140C/fi not_active IP Right Cessation
- 1987-10-28 EG EG61687A patent/EG18333A/xx active
- 1987-10-29 JP JP62272002A patent/JPS63159319A/ja active Granted
- 1987-10-29 IL IL84312A patent/IL84312A/xx not_active IP Right Cessation
- 1987-10-29 UA UA4203570A patent/UA11075A/uk unknown
- 1987-10-29 RU SU874203570A patent/RU1836079C/ru active
- 1987-10-29 PT PT86032A patent/PT86032B/pt unknown
- 1987-10-30 HU HU874900A patent/HU197987B/hu unknown
- 1987-10-30 YU YU01973/87A patent/YU197387A/xx unknown
- 1987-10-30 DD DD87308471A patent/DD262582A5/de not_active IP Right Cessation
- 1987-10-30 DK DK569687A patent/DK169308B1/da not_active IP Right Cessation
- 1987-10-30 AU AU80529/87A patent/AU598602B2/en not_active Ceased
- 1987-10-30 KR KR1019870012077A patent/KR900003491B1/ko not_active Expired
- 1987-10-30 CA CA000550706A patent/CA1314231C/en not_active Expired - Lifetime
- 1987-10-30 ZA ZA878183A patent/ZA878183B/xx unknown
-
1990
- 1990-08-09 GR GR90400533T patent/GR3000708T3/el unknown
-
1992
- 1992-10-27 LV LVP-92-174A patent/LV10051B/lv unknown
-
1993
- 1993-07-07 GE GEAP1993972A patent/GEP19971025B/en unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3732340A (en) * | 1966-07-11 | 1973-05-08 | Asta Werke Ag Chem Fab | N',o-propylene phosphoric acid ester diamides |
| US4537883A (en) * | 1982-11-12 | 1985-08-27 | Mead Johnson & Company | Lyophilized cyclophosphamide |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4959215A (en) | Ifosfamide-mesna lyophilizate and process for its preparation | |
| AU2002216042B2 (en) | Freeze-dried pantoprazole preparation and pantoprazole injection | |
| US5204335A (en) | Ifosfamide lyophilisate and process for its preparation | |
| CA1314231C (en) | Ifosphamide lyophilisate and process for its preparation | |
| CZ298581B6 (cs) | Farmaceuticky stabilní prípravek oxaliplatiny k parenterální aplikaci | |
| CN105434373A (zh) | 一种注射用奥拉西坦冻干制剂及其制备方法 | |
| AU757002B2 (en) | Pharmaceutical compositions containing the phospholipase inhibitor sodium ((3-(2-amino-1,2-dioxoethyl)-2-ethyl-1- phenylmethyl)-1H-indol-4-YL)oxy)acetate | |
| EP3040067A1 (en) | Chlorogenic acid powder-injection and preparation method thereof | |
| RU2007152C1 (ru) | Офтальмологическое средство и способ его получения | |
| US5972912A (en) | Method for lyophilizing ifosfamide | |
| DK175808B1 (da) | Ifosfamid-mesna-lyofilisat og fremgangsmåde til fremstilling deraf | |
| US7868016B2 (en) | Pharmaceutical formulations of endo-N-(9-methyl-9-azabicyclo[3,3.1]non-3-yl)-1-methyl-1H-indazole-3-carboxamide hydrochloride | |
| US11707434B2 (en) | Method for preparing organic solvent-free lyophilized cyclophosphamide | |
| EP0442958B1 (en) | Pharmaceutical composition for ophthalmic use comprising a water soluble acid addition salt of ibopamine | |
| CA2503087A1 (en) | Intravenous formulations of pyridoxal 5'-phosphate and method of preparation | |
| US3121664A (en) | Stable, hermetically sealed isotonic parenteral vehicles containing buffered warfarin sodium | |
| DE3735614A1 (de) | Ifosfamid-lyophilisat und verfahren zu dessen herstellung | |
| MX2008000669A (es) | Formulaciones farmaceuticas de hidrocloruro de endo-n-(9-metil-9azabiciclo[3.3.1]non-3-il)-1-metil-1h-indazol-3-carboxamida | |
| CN101252910A (zh) | 内-n-(9-甲基-9-氮杂双环[3.3.1]壬-3-基)-1-甲基-1h-吲唑-3-甲酰胺盐酸盐的药物制剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NDB | Extension of term for standard patent granted (sect.76) |
Free format text: 20121030 |